U.S. Authorities Investigates AstraZeneca PLC-Reuters


Thursday, 31 Oct 2013 05:35am EDT 

Reuters reported that AstraZeneca PLC is being investigated by U.S. authorities over a clinical trial that was used to win marketing approval for its new heart drug Brilinta. The British drugmaker said on Thursday it had received a civil investigative demand from the U.S. Department of Justice seeking documents and information regarding the so-called PLATO study. 

Company Quote

4469.5
4.5 +0.10%
27 Feb 2015